WallStreetZenWallStreetZen

NASDAQ: AMRX
Amneal Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

AMRX past revenue growth

How has AMRX's revenue growth performed historically?
Company
8.2%
Industry
10.04%
Market
17.15%
AMRX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AMRX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AMRX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

AMRX earnings and revenue history

Current Revenue
$2.4B
Current Earnings
-$84.0M
Current Profit Margin
-3.5%

AMRX Return on Equity

Current Company
-34.9%
Current Industry
15.4%
Current Market
188%
AMRX's Return on Equity (-34.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when AMRX announces earnings.

AMRX Return on Assets

Current Company
-2.3%
Current Industry
3.4%
AMRX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

AMRX Return on Capital Employed

Current Company
5.14%
Current Industry
5.1%
AMRX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AMRX vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
AMRX$2.39B$364.49M-$83.99M+7.56%N/A
SUPN$607.52M$90.04M$1.32M+8.24%-60.69%
TARO$610.83MN/A$45.70M-1.69%-31.12%
AVDL$27.96M-$149.13M-$160.28M-22.99%N/A
DVAX$232.28M$9.67M-$6.39M+95.19%N/A
View Top Pharmaceutical Stocks

AMRX earnings dates

Next earnings date
May 3, 2024

Amneal Pharmaceuticals Earnings & Revenue FAQ

What were AMRX's earnings last quarter?

On Invalid Date, Amneal Pharmaceuticals (NASDAQ: AMRX) reported Q4 2023 earnings per share (EPS) of -$0.58, up 1,833.33% year over year. Total Amneal Pharmaceuticals earnings for the quarter were -$98.65 million. In the same quarter last year, Amneal Pharmaceuticals's earnings per share (EPS) was -$0.03.

If you're new to stock investing, here's how to buy Amneal Pharmaceuticals stock.

What was AMRX's earnings growth in the past year?

As of Q2 2024, Amneal Pharmaceuticals's earnings has grown year over year. Amneal Pharmaceuticals's earnings in the past year totalled -$83.99 million.

What is AMRX's earnings date?

Amneal Pharmaceuticals's earnings date is Invalid Date. Add AMRX to your watchlist to be reminded of AMRX's next earnings announcement.

What was AMRX's revenue last quarter?

On Invalid Date, Amneal Pharmaceuticals (NASDAQ: AMRX) reported Q4 2023 revenue of $616.98 million up 1.18% year over year. In the same quarter last year, Amneal Pharmaceuticals's revenue was $609.76 million.

What was AMRX's revenue growth in the past year?

As of Q2 2024, Amneal Pharmaceuticals's revenue has grown 8.2% year over year. This is 1.84 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.04%. Amneal Pharmaceuticals's revenue in the past year totalled $2.39 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.